Fractyl (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 22, 2025
- Vertical
- Healthcare
- Funding URL
- View Funding Page
Company Info
- Traction
- Fractyl has demonstrated significant clinical results in early trials, showing promise in reversing type 2 diabetes symptoms in patients.
- Company Description
- Fractyl is a medical technology company focused on developing innovative solutions for metabolic diseases. Their flagship product aims to address the underlying causes of type 2 diabetes through a unique approach to metabolic health.
- Market
- Medical Technology
- Location
- Lexington, Massachusetts, USA